Celldex Therapeutics, Inc. (CLDX) Receives $8.08 Consensus Target Price from Analysts

Zacks Investment Research lowered Celldex Therapeutics from a "buy" rating to a "sell" rating in a report on Monday, July 17th. Celldex Therapeutics had 22 analyst reports since August 11, 2015 according to SRatingsIntel. The portion of a company's profit allocated to each outstanding share of common stock was $2.9 a share in the trailing twelve months. The company was downgraded on Monday, March 7 by Leerink Swann. The analysts estimated sales for the higher end at 1.6 million while the year ago reported sale was 0.5 million. For the next year, analysts expect that the firm will report sales of $13.04 million per share, with estimates ranging from $100,000.00 to $33.32 million. (NASDAQ:CLDX) is performing -27.68%. Its up 1.26% from 13.01M shares, reported previously. Raymond James Financial Services Advisors boosted its stake in stocks of Celldex Therapeutics by 26.2% through out the 1st period. The company had revenue of $3.83 million during the quarter, compared to analysts' expectations of $1.21 million. The biopharmaceutical company reported ($0.23) EPS for the quarter, beating the consensus estimate of ($0.28) by $0.05.

Valuation Ratios of Celldex Therapeutics, Inc. HC Wainwright fixed a $10.00 price objective on Celldex Therapeutics and issued the company a "buy" recommendation in a analysis note on early Wed, Aug 9th. Finally, Aegis reaffirmed a "buy" rating on shares of Celldex Therapeutics in a report on Thursday, June 29th. The average 1-year price target among brokerages that have issued ratings on the stock in the last year is $8.08. ValuEngine lowered Celldex Therapeutics from a "sell" recommendation to a "strong sell" recommendation in a analysis note on Friday morning, Sep 1st.

Several hedge funds have recently bought and sold shares of the company. Cowen & Co maintained Celldex Therapeutics, Inc.

Achillion Pharmaceuticals, Inc. has a consensus outperform rating from 8 Wall Street analysts, and the number of shares now sold short amount to at least 7.08% of shares outstanding. Meditor Group Ltd lifted its holdings in Celldex Therapeutics by 39.9% in the 2nd quarter. For the full year, analysts expect earnings to decline -25% yoy to $1.95. The stock stands almost $16.53 off versus the 52-week high of $36.83 and $4.3 above the 52-week low of $16. Northern Trust Corp now owns 2,020,797 shares of the biopharmaceutical company's stock worth $4,992,000 after purchasing an additional 219,661 shares in the last quarter. BB&T Securities LLC acquired a new stake in shares of Celldex Therapeutics during the second quarter worth about $117,000. American International Group has an ownership of 58,838 stocks of the biopharmaceutical firms shares valued $212,000 following purchasing an extra 3,880 shares through out the previous quarter, Parametric Portfolio Associates boosted its stake in stocks of Celldex Therapeutics by 2.2% through out the 1st period.

Shares of Celldex Therapeutics (NASDAQ CLDX) traded up 0.39% during mid-day trading on Wednesday, reaching $2.57. 1,544,292 shares of the company's stock traded hands. The share price has moved backward from its 20 days moving average, trading at a distance of -24.38% and stays -21.13% away from its 50 days moving average. The market capitalization of the company is at $323.49 Million. The stock stands almost -49% off versus the 52-week high and 16.36% away from the 52-week low.

Like this



21 September 2017
Man arrested after allegedly sending child porn to police
Eric Komar, a 46-year-old Hillsborough man, was arrested by special agents of the FBI Child Exploitation Task Force, officials said.

21 September 2017
AAR Corp. (AIR) Holdings Lifted by Chicago Equity Partners LLC
The company's shares were given away at $37.28 per share worth to an income of some $1,610,496 on account of Romenesko Timothy J. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink .

21 September 2017
FA tells Manchester United to act on Romelu Lukaku song
United have promised to meet Kick It Out, Greater Manchester police and supporters' groups to discuss the chant. Action will be taken against any offensive behaviour".

21 September 2017
Pretium Resources, Inc. Ordinar (NYSE:PVG) Experiences Heavier than Usual Trading Volume
BidaskClub upgraded shares of Pretium Resources from a "hold" rating to a "buy" rating in a research report on Monday, July 24th. Franklin Resources Inc. owned about 1.54% of Pretium Resources worth $26,688,000 at the end of the most recent reporting period.

21 September 2017
Jordy Nelson (quad) returned to practice for Packers on Wednesday
Those guys will all work in either the rehab group and hopefully move to limited or start in limited and hopefully move to full. Favre, who threw five interceptions in that game, was sacked on the next play after order was restored, ending the game.

21 September 2017
Panera's CEO slams McDonald's: 'Would you really eat your own kids' meals?'
The company also said it is committed to not marketing to children and provide real options for kids to choose from. Panera's CEO has a challenge for fast-food executives: Eat the meals their chains are serving children.

21 September 2017
One Nation Senator off to court over citizenship questions
Roberts was born in India in 1955 to a Welsh father and Australian mother but has argued he was only ever Australian. The court heard Roberts said he found the email addresses "from his research on the internet".

21 September 2017
Nikola And Bosch Ready To Raise The Bar On Semi-Truck Electrification
The market for electric medium- and heavy-duty trucks is in its infancy, but has drawn a growing crowd of competitors. Now the company has announced a partnership with Bosch that will focus on powertrain development for the vehicle.

21 September 2017
Wall Street edges higher; US Fed meeting in focus
China's Shanghai Composite Index dipped by 0.2%, while Hong Kong's Hang Seng Index fell by 0.4%. They will closely watch Fed Chair Janet Yellen's press conference for her views on inflation.

21 September 2017
Brokerages Set Fitbit, Inc. (FIT) Price Target at $7.30
According to analysts Fitbit Inc (NYSE: FIT)'s minimum EPS for the current quarter is at $-0.07 and can go high up to $-0.02. Separately, Executive Vice President Andy Missan unloaded 5,000 stocks of Fitbit shares in a trade dated Fri, Aug 4th.